Emcure Pharmaceuticals is planning to expand its range of products in gynaecology and dermatology in FY26. The company saw a strong 24.8 per cent growth in its domestic business in Q4FY25. It is now focusing on launching more treatments for women’s health, especially for menopause and PCOS. This builds on their earlier work in FY25 and sets the foundation for ...